- PR Newswire•6 days ago
AUSTIN, Texas, Oct. 19, 2016 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that CEO, Valerie Palmieri, will present ...
- PR Newswire•26 days ago
AUSTIN, Texas, Sept. 29, 2016 /PRNewswire/ -- ASPiRA LABs, a Vermillion company (NASDAQ: VRML), today announced a major contract agreement with CareFirst BlueCross BlueShield for their U.S. FDA cleared ...
- PR Newswire•2 months ago
AUSTIN, Texas, Sept. 9, 2016 /PRNewswire/ -- ASPiRA LABs, a Vermillion company (VRML), today announced its support for the recent US Food and Drug Administration (FDA) safety communication which recommends against the use of any screening tests for ovarian cancer. Earlier this week, the FDA announced that it is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests.
Vermillion, Inc. (VRML)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Day's Range||1.00 - 1.13|
|52wk Range||0.92 - 2.11|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.02|
|Avg Vol (3m)||43,023|
|Dividend & Yield||N/A (N/A)|